Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Colin D. Porter.
Journal of Immunological Methods | 1992
Colin D. Porter; M. H. Parkar; M. K. L. Collins; Roland J. Levinsky; Christine Kinnon
We have compared assays for products of the neutrophil respiratory burst in normal EBV-transformed B cell lines stimulated with agonists of protein kinase C. Those measuring O2- directly or its immediate product, H2O2, were successful. Of these, the most sensitive were the lucigenin- and luminol-based chemiluminescence assays for O2- and H2O2 respectively. Cell lines from CGD patients, with X-linked or autosomal recessive genetic defects in the neutrophil NADPH oxidase, did not respond in these assays, indicative of their inability to produce O2-. The defects in the lines studied encompass both proteins forming the cytochrome b-245 membrane component, and the 47 kDa cytosolic component of the NADPH oxidase. The possession of the disease associated phenotype by these cell lines provides evidence that in the normal situation both neutrophils and B cells produce O2- via the same system.
Human Gene Therapy | 1999
Katalin V. Lukacs; Colin D. Porter; Olivier E. Pardo; Ruth E. Oakley; Rachel Steel; Diane Judd; James E. Browning; Duncan M. Geddes; Eric W. F. W. Alton
To optimize gene delivery for the treatment of malignant mesothelioma, expression of the beta-galactosidase marker gene was examined in a murine model of intraperitoneal malignant mesothelioma. The beta-galactosidase gene was delivered to the peritoneal cavity of tumor-bearing mice by various plasmid-liposome complexes or by replication-incompetent retrovirus, used alone or complexed to liposomes. In tumor samples from immunodeficient nude mice, moderate levels of gene expression were achieved by liposome-complexed plasmids. Retroviral gene delivery was more effective, and was increased nearly 10-fold by complexing the retrovirus to liposomes. In contrast, in tumor samples from immunocompetent CBA mice treated with the same vectors, no marker gene expression was detected. In immunodeficient mice, tumor growth was not affected by beta-galactosidase gene transfer. However, immunocompetent mice showed a significant decrease in tumor size and increase in survival time after beta-galactosidase delivery. Induction of cytotoxic T cells capable of lysing beta-Gal-transfected tumor cells suggests that tumor cells transduced with the bacterial beta-galactosidase gene may be eliminated in immunocompetent hosts. Our findings also indicate that plasmid-liposome complexes, which achieve a low level of gene expression, and retrovirus-liposome complexes, which result in nearly 100 times higher levels of gene expression in tumor cells in vivo, are similarly effective in inducing an antitumor immune response.
Human Gene Therapy | 1996
Colin D. Porter; Mary Collins; Chetankumar S. Tailor; Mohamed H. Parkar; François-Loïc Cosset; Robin A. Weiss; Yasuhiro Takeuchi
Journal of Virology | 1998
Colin D. Porter; Katalin V. Lukacs; Gary Box; Yasuhiro Takeuchi; Mary Collins
Blood | 1994
Colin D. Porter; M. H. Parkar; A. J. Verhoeven; Roland J. Levinsky; M. K. L. Collins; Christine Kinnon
Journal of Virology | 1999
Ute Jäger; Yuan Zhao; Colin D. Porter
Blood | 1993
Colin D. Porter; M. H. Parkar; Roland J. Levinsky; M. K. L. Collins; Christine Kinnon
Biochemical Journal | 1996
Colin D. Porter; F Kuribayashi; M. H. Parkar; Dirk Roos; Christine Kinnon
Blood | 1996
Colin D. Porter; M. H. Parkar; M. K. L. Collins; Roland J. Levinsky; Christine Kinnon
Human Mutation | 1996
Colin D. Porter; Mohamed H. Parkar; Christine Kinnon